Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling. | J Biomed Sci | 2022 | 36550569 | PubTator, text mining | PubMed |
| The prognostic value of NLRP1/NLRP3 and its relationship with immune infiltration in human gastric cancer. | Aging (Albany NY) | 2022 | 36541912 | PubTator, text mining | PubMed |
| Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses. | Front Mol Biosci | 2022 | 36533074 | PubTator, text mining | PubMed |
| Pharmacological inhibition of protein tyrosine kinases axl and fyn reduces TNF-α-induced endothelial inflammatory activation in vitro. | Front Pharmacol | 2022 | 36532777 | PubTator, text mining | PubMed |
| Prevalence and clinical characteristics of T2DM patients with OTUD3 gene rs78466831 SNP at a single academic center in China. | Front Endocrinol (Lausanne) | 2022 | 36531510 | PubTator, text mining | PubMed |
| Regulation of bone homeostasis by MERTK and TYRO3. | Nat Commun | 2022 | 36509738 | PubTator, text mining | PubMed |
| The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. | Cells | 2022 | 36497148 | PubTator, text mining | PubMed |
| Dysregulation of Protein S in COVID-19. | Best Pract Res Clin Haematol | 2022 | 36494145 | PubTator, text mining | PubMed |
| Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations. | J Hepatocell Carcinoma | 2022 | 36471742 | PubTator, text mining | PubMed |
| CNS and CNS diseases in relation to their immune system. | Front Immunol | 2022 | 36466889 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 36462500 | PubTator, text mining | PubMed |
| ULTrasound-guided TRAnsfemoral puncture in COmplex Large bORe PCI: study protocol of the UltraCOLOR trial. | BMJ Open | 2022 | 36456007 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in direct contact with prostate cancer cells promote malignant proliferation and metastasis through NOTCH1 pathway. | Int J Biol Sci | 2022 | 36439868 | PubTator, text mining | PubMed |
| A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. | Dis Markers | 2022 | 36438905 | PubTator, text mining | PubMed |
| Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology. | Front Pharmacol | 2022 | 36438817 | PubTator, text mining | PubMed |
| Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. | Theranostics | 2022 | 36438481 | PubTator, text mining | PubMed |
| Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma. | Sci Rep | 2022 | 36437290 | PubTator, text mining | PubMed |
| 1,25(OH)2D3 Promotes Macrophage Efferocytosis Partly by Upregulating ASAP2 Transcription via the VDR-Bound Enhancer Region and ASAP2 May Affect Antiviral Immunity. | Nutrients | 2022 | 36432619 | PubTator, text mining | PubMed |
| Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients. | Front Cell Infect Microbiol | 2022 | 36405965 | PubTator, text mining | PubMed |
| Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma. | Genome Med | 2022 | 36404344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=26